TMCI Deepti Jain bought TREACE MEDICAL CONCEPTS, INC. shares — SEC Form 4BUYTREACE MEDICAL CONCEPTS, INC.

Deepti Jain, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 25,000 shares at $4.50 ($113K) on 2024-05-10, disclosed to the SEC on 2024-05-13.

SEC EDGAR Filing

0000950170-24-058990

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Strong73/100

Clearly above the average filing.

First-Time BuyerBuying the DipMassive Holdings Increase (>100%)Opportunistic BuyDeep Dip Buy

Trade Context

•Increased holdings by 401%
•Buying near 52-week low (+5% from bottom)
•4 other insiders also purchased in last 30 days
•Stock down -72% in previous 3 months
•Micro-Cap (Under $300M market cap — highest insider signal alpha)

Filing Info

Filed2024-05-13

Traded2024-05-10

Accession0000950170-24-058990

SourceSEC EDGAR (Historical)

Insider

NameDeepti Jain

TitleDirector

PIT GradeInsiderUnrated

View Company View Insider

Get an email when an insider at TMCI files

Free account. Follow TMCI and up to 10 more companies.

Follow TMCI for free

TMCI Deepti Jain bought TREACE MEDICAL CONCEPTS, INC. shares — SEC Form 4BUYTREACE MEDICAL CONCEPTS, INC.

Trade Context

Filing Info

Insider

Trade Details

Outcomes